High dose gammaglobulin therapy in adults with idiopathic thrombocytopenic purpura (ITP) clinical effects
✍ Scribed by Schmidt, R. E. ;Budde, U. ;Br�schen-Zywietz, C. ;Sch�fer, G. ;Mueller-Eckhardt, C.
- Publisher
- Springer-Verlag
- Year
- 1984
- Weight
- 372 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
✦ Synopsis
This study of the effect of high-dose intravenous gammaglobulins with one or two courses of therapy in 18 adults with idiopathic thrombocytopenia purpura showed a platelet rise in thirteen patients. The highest response rates were seen in splenectomized adults. In chronic patients the response was transient only. If therapy was effective, increased values of platelet-associated IgG were reduced, while shortened platelet survival times were prolonged. There was no influence of high-dose gammaglobulins on platelet function. different 7S-preparations such as beta-propiolactone modified Ig, pH 4 treated Ig and reduced and alkylated Ig have comparable effects.
📜 SIMILAR VOLUMES
Sixteen adult patients of mean age 48 years with chronic ITP were studied for platelet response to high-dose (0.4 g/kg body weight per day for five consecutive days) intravenous polyvalent intact IgG in the absence of any concurrent treatment. The platelet count returned to normal values in nine pat
Ten adult patient of chronic idiopathic thrombocytopenic purpura (CITP) used oral prednisone and were treated with seven doses of oral high-dose methylprednisolone (30 mg/kg). Nine of ten patients responded after HDMP treatment (plt > 150 × 10 9 /L). Two patients having 8 and 10 years of history ach
In four children with chronic idiopathic thrombocytopenic purpura (ITP), high doses of gamma globulin or methylprednisolone were effective in increasing platelet counts transiently, yet there was no quantitative relationship between the platelet responses to these two therapies. This finding suggest